Key Highlights
- UnitedHealth shares peaked at $404.14 this week, surging approximately 30% in the last 30 days
- First quarter revenues reached $111.7 billion, marking a 2% annual increase, while adjusted earnings per share of $7.23 exceeded analyst forecasts
- Operating margins at UnitedHealthcare expanded from 6.2% to 6.6% during the first quarter
- The company’s Medical Care Ratio declined to 83.9% in Q1, compared to 88.9% in the previous quarter
- Strategic reduction of 1.3 million Medicare Advantage members in 2026 aims to preserve profitability
UnitedHealth Group (UNH) reached a 52-week peak of $404.14 during Wednesday’s trading session, completing an impressive rally that has propelled shares approximately 30% higher over the last month.
UnitedHealth Group Incorporated, UNH
Since the beginning of the year, UNH has advanced roughly 21%. Looking at the trailing twelve-month period, the healthcare giant has delivered gains of about 29%.
This upward momentum represents a dramatic reversal from earlier this year. Between January and late March, shares plummeted from $336 down to $259 — representing a decline of approximately 23%.
The turnaround gained traction after UnitedHealth unveiled its first quarter performance in late April, delivering results that exceeded Wall Street projections and raising its full-year outlook.
First quarter revenues totaled $111.7 billion, representing a 2% year-over-year increase. Adjusted earnings per share reached $7.23, surpassing analyst expectations. On a reported basis, EPS came in at $6.90.
The UnitedHealthcare division showed margin improvement, with operating margins expanding from 6.2% to 6.6% — a relatively small but significant enhancement for an organization navigating substantial operational shifts.
Medicare Advantage Continues to Present Challenges
The Medicare Advantage program has emerged as one of UnitedHealth’s most significant operational hurdles. Federal reimbursement rates have failed to match the accelerating costs of the program, creating margin compression in recent years.
In response, UnitedHealth made the strategic decision to reduce its Medicare Advantage enrollment by 1.3 million individuals for 2026. While challenging, executives characterized this action as essential for maintaining financial health over the long term.
The financial benefits are becoming evident in recent results. The company’s Medical Care Ratio — representing the portion of premium revenue paid out for medical claims — dropped to 83.9% in the first quarter, down sharply from 88.9% in the fourth quarter of 2025.
This represents a substantial quarterly improvement and indicates that the membership reductions are already producing positive effects on the company’s cost structure.
The Year Started on a Challenging Note
The opening months of 2025 proved turbulent for UnitedHealth. Shares experienced a significant selloff in early January following disappointing fourth quarter 2024 results and a Centers for Medicare & Medicaid Services proposal that outlined Medicare Advantage rate increases falling short of industry expectations.
Additionally, the company has navigated executive transitions and faces an ongoing antitrust probe. While these concerns persist, market participants seem increasingly willing to look beyond these headwinds.
At its current valuation near $400 per share, UNH offers a dividend yield of approximately 2.3%, with a market capitalization hovering around $360 billion.
The stock’s 52-week trading range extends from $234.60 to $404.15 — with Wednesday’s peak matching the upper boundary of that range.
Wednesday’s trading volume registered around 4.8 million shares, falling short of the 8.5 million average, indicating the advance occurred without exceptionally heavy trading activity.
As of the most recent Wednesday pricing data, UNH was trading at $400.38.
